NCT06871969 Clinical Evaluation of EEG Device for the Triage of Stroke Patients in the Ambulance
| NCT ID | NCT06871969 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Condition | Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 275 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 275 participants in total. It began in 2025-07-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endovascular thrombectomy (EVT) is the standard treatment for large vessel occlusion (LVO) strokes, but it can only be performed in specialized hospitals. Since ambulance personnel cannot determine if a patient is eligible for EVT, 54% of LVO stroke patients are initially taken to non-EVT-capable hospitals, resulting in an average delay of 1 hour in time-to-EVT in the Netherlands. To reduce this delay, it is crucial for ambulance personnel to identify potential LVO stroke patients and directly transport them to EVT-capable hospitals. Dry electrode electroencephalography (EEG) has shown high diagnostic accuracy for detecting LVO strokes, but in 32% of patients, the EEG signal quality was too poor to analyze. To address this issue, TrianecT developed StrokePointer, a portable EEG-based triage device designed to collect and analyze EEG data in patients with suspected acute stroke. The objective of this study is to validate the effectiveness and safety of StrokePointer in detecting LVO stroke among patients with a suspected stroke in the pre-hospital setting.
Eligibility Criteria
Inclusion Criteria: * Suspected acute stroke as per judgement of the ambulance personnel. * Age 18 years or older. * Onset of symptoms (or last seen well) \<24 hours. * Written informed consent by patient or legal representative (deferred). Exclusion Criteria: \- Injuries or infections of the scalp in the area of the electrode headset placement.
Frequently Asked Questions
Who can join the NCT06871969 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06871969 currently recruiting?
Yes, NCT06871969 is actively recruiting participants. Visit ClinicalTrials.gov or contact Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) to inquire about joining.
Where is the NCT06871969 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands.
Who is sponsoring the NCT06871969 clinical trial?
NCT06871969 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The trial plans to enroll 275 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.